Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ahmet Anıl Özlük
Observed names:
Ahmet Anil Ozluk,
Ahmet Ozluk,
Anil A. Ozluk,
Anil Ozluk,
Anıl Özlük
Institutions:
University of Alabama at Birmingham,
UAB Medicine,
O'Neal Comprehensive Cancer Center
Observed institutions:
Akdeniz University,
University of Alabama at Birmingham,
Ege University,
Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi,
Ege Üniversitesi Tıp Fakültesi Hastanesi,
UAB Medicine,
O'Neal Comprehensive Cancer Center
show all 8
ORCID:
0000-0002-1049-330X
Observed ORCID:
0000-0002-1049-330X
OpenAlex ID:
A5107943731
Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
2023
·
Fuat Bicer
, Catrina Kure
, et al.
·
Current Oncology
·
60
PDF
Management of Older Adults With Colorectal Cancer: The Role of Geriatric Assessment
2023
·
Ahmet Anil Ozluk
, Darryl Outlaw
, et al.
·
Clinical Colorectal Cancer
·
14
PDF
Association between frailty and overall survival among older adults with hepatocellular carcinoma
2024
·
Ahmet Anil Ozluk
, Grant Richard Williams
, et al.
·
Journal of Geriatric Oncology
·
11
Pazopanib: a novel treatment option for aggressive fibromatosis
2016
·
Gulcan Bulut
, Anil Ozluk
, et al.
·
Clinical Sarcoma Research
·
11
PDF
S100A8 and S100A9 Positive Cells in Colorectal Carcinoma: Clinicopathological Analysis
2014
·
Cumhur İbrahim Başsorgun
, Betül Ünal
, et al.
·
Gastroenterology Research and Practice
·
11
PDF
Tocilizumab in the treatment of steroid refractory immune-related hepatotoxicity: a case series and review of the literature
2024
·
Ahmet Anil Ozluk
, Damla Gunenc
, et al.
·
Melanoma Research
·
10
Cancer immunotherapy
2017
·
Ahmet Anıl Özlük
·
Istanbul Bilim University Florence Nightingale Transplantation Journal
·
10
The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey
2023
·
Arif Akyildiz
, Deniz Can Guven
, et al.
·
Medicine
·
9
Efficacy of local ablative therapies in patients with solid tumors treated with immune checkpoint inhibitors and oligoprogression: a single-center analysis
2023
·
Ahmet Anil Ozluk
, Murat Karateke
, et al.
·
Melanoma Research
·
7
Circulating Tumor DNA-Based Assessment of Minimal Residual Disease in Colorectal Cancer: Prognostic and Predictive Implications
2026
·
Ahmet Anil Ozluk
, Will Colley
, et al.
·
Cancers
·
5
PDF
Real-World Impact of Metformin on Outcomes in Patients with Deficient DNA Mismatch Repair and Microsatellite Instability (dMMR/MSI) Colorectal Cancer Treated with Immune Checkpoint Inhibitors
2025
·
Garima Gupta
, Negar Sadeghipour
, et al.
·
Cancers
·
2
PDF
The impact of metformin on clinical outcomes of metastatic colorectal cancer with known molecular profile treated with cytotoxic chemotherapy or immune checkpoint inhibitor.
2024
·
Fuat Bicer
, Ahmet Anil Ozluk
, et al.
·
Journal of Clinical Oncology
·
2
PDF
The Frequency of Psychological Symptoms in the Elderly: A Cross-Sectional Field Study in Istanbul, Turkey
2023
·
Ahmet Ozluk
, Can Oner
, et al.
·
Elderly Health Journal
·
1
Differences of palbociclib and ribociclib in terms of cell death pathways; a cell culture assay
2020
·
Ahmet Ozluk
, Gulcan Bulut
, et al.
·
Research Square
·
1
PDF
A phase Ib/II, dose escalation and dose expansion study of valemetostat tosylate (DS-3201b) with atezolizumab and bevacizumab in advanced hepatocellular carcinoma (HCC).
2026
·
Mehmet Akce
, Charity Morgan
, et al.
·
Journal of Clinical Oncology
PDF
Successful application of chemosaturation with percutaneous hepatic perfusion in metastatic uveal melanoma patient progressing after systemic treatment options: a case report
2024
·
Damla Gunenc
, Ahmet Anil Ozluk
, et al.
·
Frontiers in Oncology
PDF
The impact of CARE Frailty Index on overall survival in older adults with hepatocellular carcinoma.
2024
·
Ahmet Anil Ozluk
, Grant Richard Williams
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
17
Citation count:
154
H-index:
8
I10-index:
7
Year
Topic
Type